For R&D use only.

BMS-790052

  • Catalog NO.:A897299
  • CAS No. : 1009119-64-5
  • Molecular Formula:C40H50N8O6
  • Molecular Weight: 738.88
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS

Product Details

CAS Number 1009119-64-5 Appearance
Catalog Number A897299 MDL Number MFCD17129086
Molecular Formula C40H50N8O6 Molecular Weight 738.88
Boiling Point 1071.2±65.0°C at 760 mmHg Melting Point
Flash Point Density
Synonyms Daclatasvir;BMS 790052; EBP 883; methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;Daclatasvir
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H302-H315-H319-H335 Class
Precautionary Statements P261-P305+P351+P338 Packing Group

Description

Daclatasvir (USAN), also known as BMS-790052 and EBP-883 (trade name Daklinza), is NS5A inhibitor and a drug for the treatment of hepatitis C (HCV). It is was developed by Bristol-Myers Squibb and was approved in Europe on 22 August 2014. Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA. Daclatasvir has been tested in combination regimens with pegylated interferon and ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.

1009119-65-6 (2HCl salt);

1009119-64-5 (free base) 

Related Products

My Tracks: BMS-790052
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

BMS-790052
Daclatasvir;BMS 790052; EBP 883; methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;Daclatasvir